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Abstract 
Background: Intrauterine growth restriction (IUGR) is a common diagnosis in obstetrics and 
carries an increased risk of neonatal morbidity and mortality, especially in developing 
countries. Because valid assessment of IUGR often is unavailable in low-resource settings, 
small-for-gestational-age (SGA) has been used as a proxy for IUGR. Several risk factors for 
SGA/IUGR outcome are recognized. However, the important risk factors in a specific area 
depend on the prevalence and pathology within the population of interest.  
Aims: Primary aim was to identify risk factors for SGA infants in Anuradhapura district, Sri 
Lanka. Secondary aim was to investigate if these infants have an increased risk of neonatal 
adverse outcomes and whether SGA outcome is related to a specific mode of delivery. 
Methods: The present study was a retrospective case-control study carried out in two 
demographically different areas in Anuradhapura district. SGA infants were identified by a 
population-based “weight-for-gestational-age” chart. The study sample was matched with two 
controls (2 n=272) for each case (n=136). Maternal, antenatal and postnatal information were 
collected from pregnancy records during the data collection period and later analysed. 
Results: Logistic regression analysis identified four significant factors; maternal pre-pregnancy 
weight <50 kg (OR 2.18), BMI <18.5 (OR 2.24) respectively ≥ 25 (OR 1.95), maternal height 
≤150 cm (OR 1.98) and previous low birth weight (LBW) child (OR 3.87).  
Conclusion: The significant maternal factors observed in this study may be a result of 
physiological or/and pathological influences and depending on which, modifiable or not. 
Further studies regarding this matter and studies including socioeconomic confounders are 
needed to determine the underlying cause of SGA infants in Anuradhapura district. 
Key words: Risk factors, small for gestational age, intrauterine growth restriction, case-
control study, Sri Lanka. 
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Abbreviations 
 
AGA  appropriate for gestational age 
 
CS caesarean section 
 
EDD  expected date of delivery 
 
GNI gross national income 
 
IUGR intrauterine growth restriction 
 
LBW  low birth weight 
 
LGA  large for gestational age 
 
LMP last menstrual period 
 
MOH  medical officer of health 
 
NCP northern central province 
 
PHM public health midwife  
 
POA period of amenorrhea 
 
SFH symphysis-fundal height 
 
SGA small for gestational age 
 
UNICEF       United Nations International Children's Emergency Fund 
 
WHO World Health Organization 
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Definitions  
 
Anaemia in pregnancy -  The World Health Organization (WHO) presents a haemoglobin 
(Hb) cut-off level of 11 g/dl (110g/L) or less in pregnant women. In this study, anaemia in first 
and second trimester is taken in consideration. Primary cause of anaemia during third trimester 
is plasma volume expansion and lacks the same clinical significance.  
Gestational hypertension - Blood pressure > 140/90 mm Hg after 20 weeks of pregnancy in a 
previously normotensive woman. Two measurements at separate occasions are required.  
Pre-eclampsia – A pregnancy induced high blood pressure > 140/90 mm Hg after 20 
gestational weeks, together with proteinuria ≥ 0.3 g protein/day or a urine dipstick test of ≥ 2 + 
(1).  
Small for gestational age (SGA) – Foetal weight below the 10th percentile. 
Intrauterine growth restriction (IUGR) – Atypical reduced growth of the foetus indicating 
underlying pathological process.  
Large for gestational age (LGA) – Foetal weight above the 90th percentile.  
Low Birth Weight (LBW) – A birth weight less than 2,500 grams.  
Premature birth – Birth before gestational week 37 + 0. 
Symphysis-fundal height measurement – A method used to screen for intrauterine growth 
restriction. The distance from the lowest part (pubic symphysis) to the highest part (fundus) of 
the uterus is measured (2).  
Neonatal mortality – Death during the first 28 days of life.  
Stillbirth -  Delivery of a baby at or after 28 weeks of gestation without any signs of life. This 
definition is recommended by WHO for international comparison.  
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Introduction 
General introduction 
Low birth weight (LBW) is defined by WHO as “weight at birth of less than 2,500 grams (5.5 
pounds)” (3 , p. 1). This group contributes with 60 - 70 per cent of all neonatal deaths globally. 
Overall, it is estimated that of all births worldwide 15.5 per cent are LBW and this represents 
over 20 million births a year (3). More than 95 per cent of these babies are born in low-and 
middle-income countries (4). Despite the high percentage of LBW, reliable data in this field is 
limited in less developed countries. In Sri Lanka, as a low-middle-income country, the LBW 
birth rate was 16.7 per cent in 2013 (5). According to the hospital statistics, out of 11,560 live 
births, 1966 births (17%) were classified as LBW in the year 2011 in Anuradhapura district (6). 
Any population with a LBW incidence above seven per cent is at risk of having a high perinatal 
mortality, which could be counteracted by analysing the roots of the LBW problem (7).  
LBW is a complex syndrome and can be divided into two main components; preterm birth and 
small-for-gestational-age (SGA) (4). The latter sometimes due to intrauterine growth restriction 
(IUGR). IUGR is a clinical term and usually approximated by the statistical term SGA which 
is defined as birth weight below the tenth percentile, or two standard deviations from the mean, 
at a particular gestational week (8).  
Prematurity and SGA have different causes and risks of mortality, morbidity, impaired growth 
and non-communicable diseases later in life (9). Numerous studies have focused on risk factors 
of LBW/prematurity and not the subgroup SGA. In most low-and middle-income countries, 
SGA contributes to the larger portion of LBW babies (10). The lack of division of the concept 
LBW may be a reason of incorrect focus in terms of interventions aimed to reduce 
country-/region-specific risk factors. Thus, to identify the specific risk factors for SGA is of 
great importance, especially in low-and middle-income countries where the burden of SGA 
generally is higher than that of prematurity (11).  
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Birth weight related to gestational age has long been recognized to be one of the most powerful 
predictors of perinatal outcome (12). It is important to use the appropriate “weight-for- 
gestational-age” chart to calculate the correct prevalence of SGA. The use of inappropriate 
charts may lead to misdiagnosis and misjudgement of risk factor and thereby potential 
unnecessary interventions. At the time of writing, Sri Lanka has not developed a national 
population-based birth weight reference chart of their own. There have been attempts, but the 
charts created are limited and not completed to be used at a national level. However, the 
prevalence of SGA in Colombo district has been calculated to 19 per cent by using one of these 
pilot study charts (7). Gianpaolo Maso et al. compared European and Bangladeshi growth charts 
on a Sri Lankan population and the prevalence of SGA differed between charts by 39 per cent 
(13). This study demonstrates the huge margin of error using an unfitting chart. Despite the 
difficulty finding the accurate chart, Shanumugaraja Y et al. performed a prospective study to 
validate the foetal/birthweight reference derived from WHO data and showed that WHO’s 
global reference chart adapted to Sri Lankan population centiles can be efficiently used (14).  
 
The small baby  
There are three main reasons for a small foetus. Firstly, an important and often forgotten cause 
of a SGA foetus is incorrect calculation of gestational age, hence, these foetuses are not truly 
SGA. Important sources of error are maternal recall bias of last menstrual period (LMP), 
absence of ultrasound accessibility and availability, and usage of inappropriate weight-for-
gestational -age curves. Despite the lack of official data on this matter, incorrect estimation of 
age ought to be more widespread in countries with limited resources.  
The two remaining reasons for SGA are heredity and IUGR, which act differently on foetal 
growth. Foetal growth, the increase in weight and size with increasing gestational age, is 
10 
 
primarily dependent on the genetic growth potential, the supply of nutrients and oxygen and on 
various growth factors.  
Symmetrical or asymmetrical babies 
Infants with a birth weight below the tenth percentile are a heterogenous group and their long-
term prognosis vary in a wide range, from severe growth restriction to normal growth and 
development (7). The SGA baby can either be symmetrically or asymmetrically small, and the 
two types cause diverse severity in outcome. A foetus affected by growth inhibition in an early 
stage of the pregnancy becomes symmetrically small. The growth of vital organs, such as the 
brain, is reduced in the same way as other organs and the risk of mental retardation is 
consequently more impending (15). This type of growth restriction can devolve upon early 
intrauterine infections, substance abuse or chromosomal aberration. Another reason to small, 
proportionate babies are genetic influence of the parents, but these are accordingly not growth 
restricted (7). 
The other category of IUGR babies is the ones whose weight is abnormally low in relation to 
their length, termed asymmetrical growth restriction. These babies usually have normal length 
and head circumference for full-term infants. This category represents the largest proportion in 
parts of the world with high prevalence of maternal malnutrition. Asymmetrical restriction is 
also encountered in multiple pregnancies, pre-eclampsia and other clinical conditions featuring 
an inadequate placental function. Historically, the prognosis has been considered better for the 
asymmetrical than for the symmetrical IUGR babies. However, these findings have more 
recently been challenged and studies have shown evidence of morbidity despite brain sparing 
in asymmetrical IUGR foetuses (16).  
Etiology of IUGR 
The most crucial purpose to find SGA infants is intrauterine growth restriction. According to 
Deepak Sharma et al., IUGR is defined as “the rate of fetal growth that is below normal in light 
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of the growth potential of a specific infant as per the race and gender of the fetus” (17, p. 1). 
IUGR is a clinical definition and applies to infants with features of malnutrition and in-utero 
growth retardation, irrespective of their birth weight percentile. The condition refers to a state 
when the predetermined genetic potential is not reached because of some pathologic insult (18). 
This insult can be categorized as placental, maternal, foetal or genetic, and are in some cases 
multifactorial. 
 
Figure 1. Main groups of risk factors of IUGR. Image used with permission from copyright owner Dr 
Deepak Sharma MD (Paedia), DNB Neonatology, NIMS Medical Collage, Jaipur.  
 
The most common insult in high-income countries is placental insufficiency, where the 
transport of nutrients and oxygen to the foetus decreases (19). The changes in placental function 
can be primary, without identified pathology, or conditional influence of intercurrent maternal 
diseases or pregnancy complications. Sometimes infarcts, haemorrhage and even abruption are 
seen in the placenta explaining an inferior function, but more often no explanation can be found. 
If this process is very severe the result can be a stillbirth (17).  Individual-level maternal risk 
factors continue to play a significant role in explaining LBW and IUGR outcomes. The 
nutritional state of the mother before and during pregnancy is a key factor and maternal 
malnutrition is the major cause of IUGR in low- and middle-income countries (20). Iron 
deficiency anaemia during pregnancy has in some studies been presented to correlate to IUGR 
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(21). Other identified risk factors are maternal diseases, for instance diabetes and chronic 
hypertension, and pregnancy complications such as gestational hypertension and pre-eclampsia 
(19, 22). Among the foetal causes to IUGR you find the intrauterine infections rubella, 
toxoplasmosis, cytomegalovirus infections, malaria and syphilis. These can cause permanent 
growth inhibition (15). Moreover, structural abnormalities of organ systems may be linked to 
IUGR (23). The genetic aberrations chromosomal trisomy 13, 18, 21 and different rare genetic 
syndromes are only responsible for IUGR in few cases (17).  
 
Table 1. List of important risk factors established to cause IUGR. Adapted from Bryan and Hindmarsh 
(24) and Karel Marsal et al (23). 
Maternal social conditions  
    Malnutrition  
    Low pregnancy BMI  
    Low maternal weight gain  
    Delivery at age <16 or >35 y  
    Low socioeconomic status  
    Drug use: smoking, alcohol, illicit drugs 
Medical complications  
    Pre-eclampsia  
    Chronic hypertension  
                Gestational hypertension 
    Antepartum haemorrhage  
    Severe chronic disease  
    Severe chronic infections  
    Systemic lupus erythematosus  
    Antiphospholipid syndrome  
    Anaemia  
    Malignancy  
    Abnormalities of the uterus  
 
Abnormalities of the placenta  
    Reduced blood flow  
    Reduced area for exchange  
        Partial abruption  
        Hematomas  
        Infarcts  
Foetal problems  
    Multiple births  
    Malformation  
    Chromosomal abnormalities  
    Inborn errors of metabolism  
       Intrauterine infections  
 Environmental problems  
    High altitude  
    Toxic substances  
 
 
Most IUGR infants are born with a birth weight below the lower normal range, and accordingly 
become SGA infants. Nevertheless, among children born with a normal birth weight, 
appropriate for gestational age (AGA), some are growth restricted because of pathological 
insults which prevent them from reaching their genetically programmed weight. This group of 
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AGA infants is hard to identify during pregnancy but even though growth restriction can 
influence the foetus negatively, relatively few babies fall into this group and the clinical 
relevance therefore becomes negligible. It is important to remember that not all SGA are 
pathologically small. However, since IUGR is a critical pregnancy complication, the diagnosis 
of SGA should be investigated and confirmed in order to detect threatening foetal hypoxia and 
prevent intrauterine death, which is the worst possible outcome for a growth stunted foetus (23). 
Epidemiology 
The incidence of IUGR is appraised to be six times higher in low- and middle-income countries 
when compared to high-income countries, although it is difficult to approximate the exact 
number. In figure 2 the estimated national prevalence of SGA is visualised (11). A majority of 
SGA/IUGR infants are found in Asia, which accounts for approximately 75 per cent of all 
affected infants. This is followed by the African and Latin American continents. In the Asian 
continent, the highest incidences of IUGR are seen in decreasing order in the following 
countries: Bangladesh, India, Pakistan, Sri Lanka, Cambodia, Vietnam and the Philippines, 
Indonesia and Malaysia, Thailand, and the People’s Republic of China (17). 
 
Figure 2. Estimated national prevalence of SGA births in low-income and middle-income countries in 
2010. Figure published in The Lancet, the world’s leading medical journal of global health (11).  
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Diagnosis and treatment  
IUGR is not generally associated with any clinical signs during pregnancy and therefore it is 
essential to actively search for foetuses that deviate from the normal growth curve. 
Theoretically, aberration in intrauterine growth could be discovered during pregnancy through 
ultrasound and Doppler screening. With this equipment SGA foetus with IUGR can be detected 
by biometric measurements, where abnormal umbilical artery blood flow is one of the findings 
(19). The golden standard for screening and diagnosis of IUGR in high-resource settings is thus 
foetal ultrasonography. Repeated ultrasound is also used for surveillance of SGA foetuses. 
Unfortunately, frequent ultrasound examination is inappropriate and practically impossible in 
a country with limited resources (9). Nevertheless, SGA is a commonly accepted proxy measure 
of IUGR and health care workers should search for features indicating risk for SGA infants. 
One established way to do this is to measure the symphysis-fundus height (SFH). One abnormal 
SFH-measure value has a low predictive value, but due to the method’s simplicity and low cost 
measuring can be repeated. By serial measurements, 55-60 per cent of SGA foetus can be 
recognized (23). However, there are studies showing that SFH-determination only detects a 
small fraction of all SGA infants in low-risk population (25).  
Another way to identify pregnant women with risk of growth restricted foetuses is to pay 
attention to risk factors. It can be anamnestic information, predisposing diseases or 
complications during current pregnancy (23). Lindquist and Molin manifested in a large 
retrospective single-centre trial that SGA detected during pregnancy have significant better 
outcome and prognosis than the ones first diagnosed after the delivery (26). 
Currently there is no specific treatment for IUGR. The initial management comprises 
elimination of recognized sources of impaired growth and encouragement of a healthy 
intrauterine environment. Measures such as improved nutrition, smoking cessation and control 
of maternal illnesses are important. When present, treatment of infection diseases is mandatory. 
15 
 
For the time being, the primary intervention consists of establishing structured antenatal 
surveillance programs. It is of immense importance to deliver the child before severe hypoxia 
has been established in order to prevent permanent brain damage or stillbirth (27).  
Short- and long-term consequences 
The problems of being small at birth was already described in 1988 by Arja Tenovuo et al. It 
starts at first breath with hypoxemia, hypoglycaemia, polycythaemia and difficulties 
maintaining normal body temperature. These are only some of the obstacles SGA babies have 
to face to a higher extent compared to babies with normal birth weight (28). Some studies 
describe more adverse outcomes of small infants born with a gestational weight below the 5th 
and 3rd percentile (29). The most severe outcome is nevertheless a stillbirth. A systematic 
review and meta-analysis describes that the risk factors placental abruption and SGA have the 
greatest population-attributable risk of stillbirth (23% respectively 15%) (30). 
Lately more research has focused on long-term consequences of being small at birth. Follow-
up studies on growth restricted infants state that SGA children remain small for their age into 
school age. Stunting during this period is related to poor outcomes in health, cognitive 
development, and educational and economic attainment later in life (31). These individuals 
have somewhat lower IQ, neurological abnormalities and changes in cardiovascular function 
compared to controls born AGA (23). When it comes to cardiovascular diseases, people born 
SGA have an increased incidence of metabolic syndrome, coronary artery disease and stroke as 
adults (32). The increased morbidity of adulthood creates severe and unnecessary suffering, 
especially at an individual level, but likewise puts strain on the resources of the society.  
 
Global health goals  
Low birth weight has been established as an important public health indicator. Globally, LBW 
is a good summary measure of a complex public health problem including long-term maternal 
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malnutrition, bad health, hard work and poor pregnancy health care (3). Even though LBW is 
ordinarily used as an indicator of child health, LBW-index has its limitations due to discounting 
gestational age. This makes the index a heterogenous entity that includes both infants who are 
SGA and those who are preterm (19). Assessing gestational age cannot be overemphasized as 
it helps to anticipate complications the neonate might have to face. Differentiation of infants 
born SGA respectively preterm, rather than with merely low birth weight, may guide prevention 
and management strategies to speed progress towards the goal to reduce global child mortality 
(9).  
WHO’s global targets for 2025 
Member states of WHO endorsed in 2012 six global targets to improve the nutrition in mothers, 
children and infants by the year 2025. One of the targets was a 30 per cent reduction in LBW 
rate. This would in numbers correspond to a reduction from approximately 20 million to 14 
million infants born with a birth weight below 2,500 grams. A number of actions have been 
listed to prevent LBW: peri-conceptional daily folic acid supplementation, foetal growth 
monitoring and neonatal size evaluation at all levels of care, decrease in non-medically 
indicated caesarean deliveries and antenatal balanced protein–energy supplementation to 
selected women. In context to these actions, WHO declares that the goal will not be achieved 
if not pregnancy care is combined with appropriate neonatal medical and nutritional care for 
preterm respectively SGA (33). 
Sri Lanka  
The national situation 
Sri Lanka is an island state in South Asia, situated south-east of India, with a population of 
20.77 million people (2015). According to The Wold Bank Group, Sri Lanka is rated as a low- 
middle-income country and the gross national income (GNI) is 3.8 USD per capita (2015). 
Poverty is major problem, but despite this people live longer than in many other countries with 
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similar GNI. The life expectancy at birth is one of the highest in South Asia and was 74.8 years 
in 2014 (34).  Sri Lanka, as a low-middle-income country, has done huge progress when it 
comes to public health actions. Development can be observed in terms of health indicators such 
as rise in average life expectancy and lower child mortality. At present, 99 per cent of all 
childbirths take place in medical institutions and almost 99 per cent of all deliveries receives 
trained assistance (35). Despite the large investments within the health sector, the nutritional 
status of children has not significantly improved over the years. Child undernourishment is 
especially pronounced among the population in the northern and eastern parts and UNICEF 
declares Anuradhapura as one of the districts with the highest prevalence (36). Christian et al. 
provides strong evidence of a positive association between malnutrition and SGA in an 
extensive meta-analysis of 19 longitudinal birth cohorts (37). Furthermore, the local researcher 
Dr Ruwan Pathirana state that the stagnation of LBW rates in Sri Lanka is explained by an 
increase rate of SGA babies while the rate of premature babies has decreased over the last 
decade (38). 
Maternal and child health care system  
Health units of Sri Lanka have a defined geographical area. The units correspond to the 
administrative divisions of the country and each area is managed by a Medical Officer of Health 
(MOH). This person is supported by a team of different public health personnel. One personnel 
category is the Public Health Midwives (PHM) and one MOH is supported by 20-25 PHMs.  
The smallest working unit in the government health system is the Public Health Midwife area 
(PHM area), which comprise several villages consisting 2,000-4,000 people. The PHM 
provides domiciliary maternal and child health care service and is in this way the “front line” 
health worker. The work is accomplished by systematic home visits during antepartum and 
postpartum. To routine and plan the daily visits the PHM use a system of record keeping. The 
pregnancy record is one of these records and it contains vital information about the health state 
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of the mother during antepartum, information about the intrapartum period as well as 
postpartum period. Medical officers have the possibility to document in the pregnancy record 
during mother’s hospital visits (35). 
 
Medical relevance 
The morbidity and mortality of SGA infants can be reduced if maternal risk factors are detected 
in an early stage and managed by simple methods. Thus, it is necessary to identify current risk 
factors responsible for SGA in a specific area as IUGR depends on the prevalence of risk factors 
and pathology within the population. The risk factor profile among women in Anuradhapura 
district has not been previously investigated. The findings of this study could contribute to 
understanding and help to distinguish were to direct interventions of maternal care before and 
during pregnancy. Results could be useful to set up a more individual care plan for the mother 
regarding to her risk profile. The study can also contribute to current knowledge about low birth 
weight, and more specific, small for gestational age. 
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Aim 
The primary aim of this study was to identify significant maternal and antenatal factors that 
correlate with birth of SGA infants in Anuradhapura district, Sri Lanka. The second aim was to 
investigate whether SGA outcome correlate with increased risk of adverse outcomes, such as 
birth or postpartum complications and neonatal deaths, but also to investigate if SGA is 
associated to a specific mode of delivery. 
 
Material and methods 
Settings and study population 
A retrospective case-control comparative study was achieved and the data collection was done 
during a six-week period in Sri Lanka. Data were taken from pregnancy records from the years 
2014-2017 in 13 PHM areas. The records were stored in PHM offices, which happened to be 
either a clinic or more often the PHMs home. Data was collected from two demographically 
different MOH areas; the more rural Mihintale area and the urban area Nuwaragam Palatha. 
Cases were identified as infants with a birth weight below the tenth percentile. All SGA children 
with mothers resident in the two MOH areas during time of birth were eligible for inclusion. 
Controls had a birth weight between the 10th and 90th percentile and thereby AGA. Thus, infants 
born large for gestational age (LGA) were excluded in this study. Exclusion of multiple 
pregnancies was also done as the risk of low birth weight are impending. Births after 43 weeks 
of gestation were excluded. Because of no registrations of birth weight of stillborn babies, these 
could not be included in the study.  
The final sample size was calculated to n=136 cases and 2 n= 272 controls. Two controls were 
matched for each case, assembled as a set. Four groups were used for matching; extremely 
preterm (< 30+0 weeks), preterm (≥ 30- 36+6), term (≥ 37- 41+6) and postterm (≥42+0 weeks). 
To optimize the matching, same gestational week of birth of case and controls was preferable 
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chosen if possible. All matched sets except three came from the same PHM area and the 
remaining three were from the same MOH area.  
As a first step, all records from a PHM office were screened for SGA by examination of the 
birth weight. Possible case-subjects were identified as infants with a birth weight lesser than 
2938 grams. This specific weight equals the heaviest infant born SGA in week 43. To decide if 
an infant was SGA or not, the second step was to assess the gestational age. Below is an 
explanation how this assessment was carried out.  
 
Study instruments needed to determine category of infant  
Gestational age at birth. At the first antenatal visit, assessment of gestational age was 
performed by calculating the number of completed weeks since the first day of the mothers 
LMP. Determination of gestational age from an early ultrasonic measurement (<20 weeks) is 
the golden standard and was used if registered. To calculate the gestational week of birth, the 
expected date of delivery (EDD) was used. The due date is considered 280 days after the start 
of LMP, known as Naegele’s rule. The number of days between the EDD and the actual date 
of birth was reckoned. The gestational age at birth was registered in whole weeks. If the age 
was calculated to 38+3 it meant that 38 weeks of gestation had been fulfilled.   
Birth weight. The weight-chart reference extended from gestational week 24-41. To avoid 
exclusion of infants born week 42 and 43, an extrapolation was made in collaboration with Dr 
Håkan Lilja, Sahlgrenska University.  
Weight-for-gestational-age chart. The population-based weight chart used in this study is based 
on a computer program. This program is created on foetal weight equation proposed by Hadlock 
et al. (39) and further technical details is described in the journal article of Mikolajczk et al. 
(40). The mean birth weight (SD) at 40 weeks of gestation was determined to 3140 grams 
(432g), in accordance to a previous study carried out on a Sri Lanka population (14). 
21 
 
Table 2. WHO’s global reference birth weight-chart based on Sri Lankan mean birth weight (SD) at 40 
weeks of gestation; 3140 grams (432g), used to find cases and controls. 
 
 
 
 
 
 
The third step, when possessing the infant’s gestational age and birth weight, was to apply 
WHO’s birth weight chart to identify a possible case. A weight below the tenth percentile for 
the specific gestational week was defined as SGA. The same three-steps procedure was done to 
recognize controls. The selected controls were the two matched, AGA babies born closest 
before respectively after the case-subject within maximum one year. A one-year span limit was 
selected with the intention of diminishing social and environmental changes within the PHM 
area. 
 
 
 
 
 
Figure 3. Flow chart of the selection of the sample.  
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Data collection  
When finding a case and associated controls, a premade datasheet of all parameters of interest 
was used to gather the data. To save time, photo copies were taken to be able to fulfil the 
collection later out of PHM office. Variables required translation, as well as hardly readable 
notes and other question marks, were filled in out in field. If anything had to be clarified later 
on, there were always possibilities to get hold of the PHM afterward.   
Local assistance 
The pregnancy records were written by hand in Sinhalese by the PHM. Translation from the 
local language to English was carried out voluntarily by 20 students from the Health Promotion 
Study Programme at Rajarata University, Mihintale. All students were doing their third and last 
year of study and some basic medical knowledge is included in their programme. Before the 
sampling, they were informed about the study during a two hour long gathering, reviewing the 
study design, objectives, methods, data variables and important aspects of data collection at the 
PHM office. They also had a lecture about how to calculate gestational age in order to reduce 
the time with the PHM.  
 
Exposure variables  
All variables were taken from the pregnancy record and comprised previously known risk 
factors as well as less studied ones. The major part of variable selection was done a head of 
departure in consultation with the Swedish supervisor. In attempt to capture the overall 
perspective, not only medical but social risk factors such as education, occupation and marital 
status were also considered. Unfortunately, because of discrepancy in received information the 
influence of several interesting variables such as smoking, substance abuse and chronic 
hypertension turned out to be impossible to investigate. Furthermore, the 
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evaluative measure “Apgar score”, considered to be a proxy measure to report morbidity at 
birth, was lost.   
 
Table 3. Variables sampled from pregnancy records; described and categorized in collaboration with 
Dr Håkan Lilja, Sahlgrenska University. 
 
Variable How data was logged* 
Maternal risk factors  
Age of mother 
 
<18 
18-34 
≥ 35 
Level of education  
 
Grad 1-9 
Higher education 
Occupation  
 
Unemployed/housewife   
White collar 
Blue collar 
Parity Primiparous 
Multiparous  
Obstetric history: 
- Previous LBW (<2500g) 
- Previous miscarriage 
- Previous CS (caesarian section) 
Yes/no 
Family history of: 
- Diabetes mellitus  
- Hypertension 
- Hemorrhagic disease 
Yes/no 
Marital status Unmarried  
Married 
Consanguinity Yes/no 
History of subfertility Yes/no 
Antepartum haemorrhage (in current pregnancy)  Yes/no 
Present diseases: 
- Diabetes mellitus  
- Malaria  
- Cardiac disease 
- Renal disease 
- Asthma  
Yes/no 
Pre-pregnancy weight (kg) (before 12 weeks of POA) <50 
>50 
Maternal height (cm) ≤ 150 
151–160 
>160 
Weight gain during pregnancy Below  
Within 
Above 
Pre-pregnancy BMIa (before 12 weeks of POA) <18.5 
18.5-24.9 
≥ 25 
Gestational hypertension  Yes/no 
Pre-eclampsia Yes/no 
Syphilis  Yes/no 
HIV Yes/no 
Anaemia in pregnancy (<11 g/dl, <110 mg/ml) Yes/no 
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Antenatal and delivery factors   
Folic acid supplementation in early pregnancy  
(before POA 12 weeks) 
Yes/no 
SFH-chart data Normal 
Pathologic  
Mode of delivery Vaginal delivery 
Caesarean section  
New-born  
Prematurity (<37 weeks)  Yes/no 
Sex Male 
Female 
Birth complications Yes/no 
Postpartum complications No 
Infections 
Abnormalities 
Neonatal death 
 
No 
< 8 days 
8-28 days 
*Bold subgroup of each specific variable indicates references group in the statistical analysis. aBody mass index.  
 
 
Clarifications of primary aim variables 
Consanguinity. In this study consanguinity is defined as a marriage between two individuals 
who are related as second cousins or closer.  
Weight gain during pregnancy. A pregnant woman was at the first antenatal visit (≤ 12 weeks) 
addressed to a specific BMI-group (A-D) based on her height and weight. The total pregnancy 
weight gain was estimated by subtracting the pre-pregnancy weight from the last measured 
weight before delivery, which always was registered in third trimester. With this information, 
it was possible to determine if the woman had gained the adequate number of kilograms 
regarding to her BMI-group. The total weight gain could be below, within or above her expected 
weight gain range. 
 
Table 4. Normal weight gain during pregnancy in relation to BMI-group. Guidelines issued by 
the Institute of Medicine (IOM). 
Group BMI (kg/m2) Expected weight gain (kg) 
A- Undernutrition <18.5  12.5-18 
B- Normal 18.5 – 24.9  11.5-16 
C- Over weight 25 – 29.9 7.0-11.5 
D- Obese ≥ 30  ≤ 6.8 
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SFH-chart data. The chart used was based on a Western population, which meant that the birth 
weight means drawn as two parallel lines in the chart was not equivalent to the mean in our 
study population. The chart was designed to detect growth abnormalities with a series of 
measurements and abnormal growth would be caught by the shape of the curve rather than from 
a single plotted value (41). Consequently, if only one measurement was registered it was 
handled as missing data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. On the left hand, the weight gain chart and on the right the SFH-chart, both extracted from the 
A card of the pregnancy record. In the weight chart, the mothers weight gain during pregnancy was 
plotted and the areas A-D represent her initial BMI-group. In the SFH-chart, fundal height was plotted 
in relation to gestational age.  
 
Level of education. In Sri Lanka, schooling is compulsory for children aged 5 to 14 years old, 
corresponding to grade 1-9. Mothers who had continued higher studies, and eventually 
completed university entrance exam and later a degree, were in this study referred to as “higher 
education”.  
Occupation. It was possible to distinguish two types of occupations; blue- and white-collar job. 
The blue-collar worker was a mother who had a physically demanding job and typically worked 
under adverse and strenuous conditions (for example monotonous work, lifting and carrying 
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heavy loads, poor posture). In contrast, the white-collar worker had a more mentally and 
emotionally demanding job, which meant a greater psychological stress. The distinction 
between white-and blue-collar job was performed by the author.  
 
Secondary aim outcomes 
Birth complications. Complications during labour; acute asphyxia, prolonged and obstructive 
labour, meconium aspiration and abnormal heart rate pattern.  
Postpartum complications. Divided into two types of observations; infections and 
abnormalities. “Infections” included respiratory infections, infection in the umbilicus and 
neonatal sepsis. The term “abnormalities” included any congenital abnormality.  
Mode of delivery. Vaginal delivery included assisted delivery with forceps and ventouse.  
 
Assumptions 
The variable “hypertension in pregnancy” was noted as present or not in the pregnancy record. 
Confirmed by the PHM, this hypertension related to the current pregnancy and were 
documented by the medical doctor at the clinic. In some of the records there was a diagnosis of 
hypertension in pregnancy, but no registrations of high blood pressure were documented. We 
assume that the medical doctor has completed unregistered measurements and is acquainted 
with the definition of gestational hypertension. Furthermore, another assumption was that the 
pre-pregnancy weight was similar to the mother’s weight at the first antenatal visit (≤ 12 weeks). 
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Statistical analysis 
The data were stored and coded in Excel and analysed using IBM SPSS statistic version 24. In 
the description of demographic and clinical variables, continuous data was presented as means 
and standard deviations, whereas discrete (nominal and ordinal) data as numbers and 
percentages. Logistic regression assumes linearity of independent variables. Whilst it does not 
need the dependent and independent variables to be connected linearly, the independent 
variables must be linearly connected to the log odds. Otherwise the test underestimates the 
strength of the relationship and a potential correlation is rejected too easily. In order to 
circumvent this problem, interval variables were categorized and made nominal before analysis.  
To test the probably of independence, Pearson’s chi square test was used and Fischer´s exact 
test when appropriate due to small cell size (less than five observations in one cell). From the 
unadjusted tests, the variables which presented p-values <0.1 where further analysed in the 
multivariable adjusted analysis. To not lose potential confounders in the logistic regression, a 
change of alpha level from <0.05 to <0.1 was made. Spearman’s rank correlation test was 
performed to examine the degree of correlation between variables intended to be included in 
the multivariable analysis. All variables of interest with a p-value below 0.1 in the unadjusted 
tests presented a correlation coefficient <0.2, indicating independence of each other. 
To measure the obtained associations, adjusted odds ratio and confidence intervals were 
calculated with binary logistic regression. Hosmer and Lemeshow test were used as goodness 
of fit statistics. To investigate maternal pre-pregnancy BMI, weight and height independently, 
two separate models were created. Since the number of cases was relatively small, two models 
with fewer independent variables in each model would also strengthen the results of the 
analysis. Statistical significant p-value was considered when p < 0.05. Infant sex was entered 
as a predictor for SGA and added to both regression models. Even though maternal age, level 
28 
 
of education or parity showed no correlations to the studied outcome in the unadjusted tests, 
they were considered potential confounders and therefore included in the models.  
 
Ethical considerations  
Ethical approval for data collection was received from the Ethics Review Committee, Faculty 
of Applied Sciences of Rajarata University of Sri Lanka (see Appendix, Annex 1). All 
pregnancy records were formerly given identity number and there by impossible to connect to 
the individual. The obtained data was subsequently treated anonymously. The study obeys the 
human rights and the Declaration of Helsinki ethical principles for medical research. 
Results 
Study population 
Data were collected from 408 pregnancy records of women in Anuradhapura district including 
maternal and pregnancy characteristics, antenatal care, labour characteristics, neonatal 
complications and death. 136 cases respectively 272 controls were included in the study, where 
51.7 per cent (n=215) were males and 46.4 per cent (n=193) were females. 53.7 per cent 
(n=219) of the population came from Mihintale MOH area and 46.3 per cent (n=189) from 
Nuwaragam Palatha MOH area. All mothers to cases and controls included were married. The 
SGA prevalence among new-borns in these two areas were 5.4 per cent in this study. To access 
the severity of SGA, calculation of the 5th and 3rd percentile was performed. Out of the total 
number of SGA (n=136), 57.4 per cent (n=78) was below the 10th centile, 14.7 per cent (n=20) 
below the 5th, and 27.9 per cent (n=38) below the 3rd percentile. 15 of 136 (11%) SGA infants 
were preterm and the residue were born term SGA. No extremely preterm or postterm infants 
were found during screening. Additional clinical characteristics of the study population are 
presented in table 5. 
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Unadjusted univariate analysis 
As seen in table 6, Pearson’s Chi-square test presented a significant connection for the maternal 
anthropometric factors pre-pregnancy weight, height and pre-pregnancy BMI, indicating an 
association between both maternal weight respectively height and having a small infant for 
gestational age. Previous LBW child and mode of delivery also showed significant association 
to outcome of interest. Because of limited observations in some of the subgroups, analysis of 
marital status, present malaria, infections (HIV/syphilis), pre-eclampsia and SFH-chart data 
could not be completed with valid results. Consequently, these specific variables could not be 
tested for predictors of having a SGA infant. Analysis of family history of haemorrhagic 
diseases, present diabetes, heart- and renal diseases as well as gestational hypertension yielded 
no association to SGA (p-value 1).   
Table 6. Description and unadjusted univariate analysis of demographic, clinical, antenatal and 
postnatal factors. Number of cases, controls and valid percentage. Missing subjects in numbers.  
                                                                        No. (%) 
 
Maternal factors 
Total study population 
(n=408) 
Case, SGA  
(n= 136) 
Control, AGA 
(n=272) 
P-value 
Maternal age (y)    0.509 
    <18  10 (2.4)  5 (3.7) 5 (1.8)  
    18-34  350 (84.1) 116 (85.3) 234 (86.0)  
    ≥35  48 (11.5) 15 (11.0) 33 (12.1)  
Marital status    NA 
    Unmarried 0 0 0  
    Married 408 (100) 272 (100) 136 (100)  
 
Table 5. Maternal and new-born clinical characteristics of the study population; in total and 
comparison between the case and control group. 
  
Controls. AGA infants 
 
Case. SGA infants 
 
Total study population. 
 Mean 
(SD) 
Min. Max. Mean 
(SD) 
Min. Max. Mean 
(SD) 
Min. Max. 
Birth weight (g) 2806 
(319) 
1446 3600 2257 
(329) 
700 2760 2623 
(413) 
700 3600 
Gestational age (wk) 38 (2) 31 41 39 (2) 30 41 38 (2) 30 41 
Maternal age (y) 28 (6) 16 41 27 (5) 17 44 28 (6) 44 16 
Pre-pregnancy weight (kg) 
(missing =48) 
52.7 
(10.5) 
34.0 85.0 49.1 
(11.5) 
30.5 83.6 51.6 
(10.9) 
30.5 85.0 
Height (cm) 
(missing =12) 
155 (6) 142 172 152 (6) 139 180 154 (6) 139 180 
Initial BMI (kg/m2) 21.9 (4.2) 13.6 37.3 21.1 (4.8) 12.7 37.2 21.7 (4.4) 12.7 37.3 
Weight gain (kg) 9.7 (4.1) 1.0 23.6 9.5 (4.5) 1.7 22.0 9.7 (4.2) 1.0 23.6 
Abbreviations: SD; standard deviation. Min.; minimum. Max.; maximum.   
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Consanguinity 24 (5.8) 12 (8.8) 12 (4.4) 0.074 
Level of education    0.459a 
    Grad 1-9 176 (42.3) 55 (40.4) 121 (44.5)  
    Higher education 232 (55.8) 81 (59.6) 151 (55.5)  
Occupation    0.912 
    Unemployed/housewife 301 (74.1) 102 (75.0) 199 (73.7)  
    White-collar 91 (22.4) 30 (22.1) 61 (22.6)  
    Blue-collar 14 (3.5) 4 (2.9) 10 (3.7)  
    Missing 2 0 2  
Family history of      
    Diabetes mellitus 55 (13.2) 17 (12.5) 38 (14.0) 0.682 
    Hypertension 52 (12.5) 15 (11.0) 37 (13.6) 0.462 
    Hemorrhagic disease 2 (0.5) 1 (0.7) 1 (0.4) 1.0a 
Present diseases     
    Diabetes mellitus 5 (1.2) 2 (1.5) 3 (1.1) 1.0a 
    Malaria 1 (0.2) 0 (0) 1 (0.4) NA 
    Cardiac disease 2 (0.5) 1 (0.7) 1 (0.4) 1.0a 
    Renal disease 2 (0.5) 1 (0.7) 1 (0.4) 1.0a 
    Asthma 13 (3.1) 5 (3.7) 8 (2.9) 0.767a 
    Infections (Syphilis/HIV) 0/0 (0) 0/0 (0) 0/0 (0) NA 
Pre-pregnancy weight (kg)    <0.001* 
    <50  165 (45.8) 68 (59.1) 97 (39.6)  
    >50     195 (54.2) 47 (40.9) 148 (60.4)  
Height (cm)    0.007* 
     ≤ 150 118 (29.2) 52 (38.8) 66 (24.4)  
    151-160 229 (56.7) 69 (51.5) 160 (59.3)  
    >160 57 (14.1) 13 (9.7) 44 (16.3)  
    Missing 4 2 2  
Pre-pregnancy BMI (kg/m2)    0.003* 
    <18.5 93 (26.0) 41 (36.0) 52 (21.3)  
    18.5-24.9 185 (51.7) 45 (39.5) 140 (57.4)  
    ≥25 80 (22.3) 28 (24.6) 52 (21.3)  
    Missing 50 22 28  
Obstetric history     
Parity    0.177 
    Primiparous 170 (40.9) 63 (46.3) 107 (39.3)  
    Multiparous 238 (57.2) 73 (53.7) 165 (60.7)  
History of subfertility 13 (3.1) 7 (5.1) 6 (2.2) 0.136 
Previous LBW 74 (17.8) 40 (29.4) 34 (12.5) <0.001* 
Previous miscarriage 64 (15.4) 21 (15.4) 43 (15.8) 0.923 
Previous CS 52 (12.5) 14 (10.3) 38 (14.0) 0.294 
Antenatal and delivery factors     
Weight gain during pregnancy     0.471 
    Below 170 (47.8) 58 (51.3) 112 (46.1)  
    Within 133 (37.4) 37 (32.7) 96 (39.5)  
    Above 53 (14.9) 18 (15.9) 35 (14.4)  
    Missing 52 23 29  
Antepartum haemorrhage 9 (2.2) 4 (2.9) 5 (1.8) 0.489a 
Gestational hypertension 11 (2.6) 4 (3.0) 7 (2.6) 1.0a 
Pre-eclampsia  1 (0.2) 1 (0.7) 0  NA 
Anaemia in pregnancy  111 (26.7) 45 (33.8) 66 (25.1) 0.067  
Folic acid    0.062 
    No 134 (32.2) 53 (39.0) 81 (29.8)  
    Yes 274 (65.9) 83 (61.0) 191 (70.2)  
SFH-chart data    NA 
    Normal 281 (100) 88 (64.7) 193 (71.0)  
    Pathologic  0 0 0  
    Missing 127 48 79  
Mode of delivery    0.012* 
    Vaginal delivery 271 (66.4) 79 (58.1) 192 (70.6)  
    CS 137 (33.6) 57 (41.9) 80 (29.4)  
New-born     
Sex    0.161 
    Female  193 (46.4) 71 (52.2) 122 (44.9)  
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    Male 215 (51.7) 65 (47.8) 150 (55.1)  
Birth complications  0  0 0 NA 
    Missing 5 2 3  
Postnatal complications    NA 
    No 369 (88.7) 124 (99.2) 245 (99.6)  
    Abnormalities 1 (0.2) 1 (0.8) 0 (0)  
    Infections  1 (0.2) 0 (0) 1 (0.4)  
    Missing 37 26 11  
Neonatal death 0 0 0 NA 
Abbreviations: NA, non-analytical. Analysis of some variables could not be done since the number of observations was too 
few to get results of enough reliability. These affected variables were; marital status, present infectious diseases, pre-
eclampsia, SFH-data, birth complications, postnatal complications and death. a Fisher’s exact test. *p-value <0.05 
 
A total of 127 (31.1%) pregnancy records were missing complete SFH-chart data and could not 
be analysed. Out of the remaining 281 (68.9%) records, all presented a normal plotting of 
measurements in the chart. No abnormalities such as stagnating or declining curves were found 
indicating possible pathologic growth restriction. 
 
Logistic Regression Analysis  
Multivariable logistic regression analysis was performed to assess to what extent factors 
obtained from the univariable analysis were affecting SGA births. In the adjusted analysis, 
clinical variables low maternal pre-pregnancy weight (<50 kg), low maternal stature (≤ 150 
cm), pre-pregnancy BMI <18.5 and ≥ 25 were significantly higher in the SGA group (table 7). 
The odds ratio was more than 1 for all statistical significant variables in the analysis, expressing 
more extreme values of these variables, the greater is the odds to have a SGA infant. Shown in 
both regression models, mothers with previous LBW child (< 2500g) were approximately four 
times (OR 3.8) at higher risk for having a SGA infant as compared to mothers with no history 
of LBW birth (p <0.001). A tendency to significant increased risk of SGA was seen in the 
univariable test for the variables consanguinity, lack of folic acid supplementation in early 
pregnancy and anaemia in pregnancy. However, these borderline associations were gone in the 
multivariable analysis.  
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Table 7. Result of binary logistic regression analysis. Odds ratio for the dependent variable (SGA 
outcome) with 95% confidence interval and significance, is shown for maternal and antenatal factors. 
Model 1 and 2 were mutually adjusted for maternal age, level of education, parity and infant sex. 
 
 Independent variable OR  Lower (CI 95%) Upper (CI 95%) Sig. 
Model 1 Consanguinity 1.95 0.69 5.58 0.210 
 Folic acid 1.44 0.84 2.49 0.186 
 Anaemia in pregnancy 1.37 0.77 2.41 0.285 
 Pre-pregnancy weight (kg)     
     <50 2.18 1.28 3.69 0.004* 
      >50 (reference) 1    
 Height (cm)    0.028* 
     ≤ 150 1.98 1.14 3.45 0.015* 
     >160 0.82 0.37 1.82 0.615 
 151–160 (reference) 1    
 Previous LBW 3.87 1.98 7.57 <0.001* 
      
Model 2 Consanguinity  1.61 0.59 4.44 0.354 
 Folic acid 1.33 0.78 2.28 0.295 
 Anaemia in pregnancy 1.32 0.76 2.32 0.325 
 Pre-pregnancy BMI (kg/m2)    0.010* 
     <18.5 2.24 1.27 3.94 0.005* 
      ≥ 25  1.95 1.04 3.64 0.036* 
 18.5-24.9 (reference) 1    
 Previous LBW 3.87 2.01 7.47 <0.001* 
Abbreviations: Odds ratio (OR), confidence interval (CI), significance (Sig.). *P-value <0.05. 
 
Mode of delivery and neonatal outcome 
In the SGA-group, 41.9 per cent (n=57) were delivered by caesarean section (CS) compared to 
29.4 per cent (n=80) in the AGA-group, representing a significant difference between the 
groups (p-value 0.012). Regarding the second aim of the study, which was to investigate the 
link between SGA infant and adverse neonatal outcomes such as birth and postpartum 
complications, too few observations made it impossible to analyse the data statistically. Only 
two postnatal complications were documented in total; upper respiratory tract infection 
requiring neonatal intensive care and retentio testis. No birth complications were documented 
and there were no neonatal deaths. 
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Discussion  
The present study shows that maternal body size is associated with a higher risk of having an 
infant too small for gestational age in the investigated MOH areas. More exactly short stature 
(≤ 150), low pre-pregnancy weight (<50 kg) and BMI (<18.5 and ≥25). An increased risk of 
SGA among mothers with a previous history of LBW birth was also found.  
The result regarding short stature is in line with several prior studies where the study outcome 
has been both SGA respectively IUGR (42-44). Likewise, many researchers have demonstrated 
that mothers of SGA infants by population centiles have lower initial weight than those of AGA 
infants (44-46). In the light of these findings, it is not remarkable that low BMI (<18.5) is 
associated with a more than twofold increased risk of SGA. In Vietnam, Ota et al. showed an 
increased risk of SGA among women with BMI <18.5 (47). However, more outstanding is the 
significant relation between high pre-pregnancy BMI (≥ 25) and the likelihood of having a 
small infant. Other researchers have earlier presented no or a reverse association, reporting BMI 
≥ 25 as a protective factor (43, 48). A likely explanation to the association between overweight 
and SGA could be that there is no direct effect of BMI ≥ 25, what we see is rather an indirect 
effect mediated by hypertension and diabetes with vascular disease (49). The disparity in result 
could also be explained by the failure of taking important social confounders into consideration. 
It is seen in previous studies that LBW tend to repeat in families (50). However, most of these 
studies have not considered LBW as a composition of prematurity and SGA. It is well-
recognized that one of the main risk factors for premature delivery is previous premature 
delivery. Bakewell at al. investigated LBW repetition and demonstrated an increased risk for 
LBW with previous LBW divided into three groups; preterm non-SGA (OR 7.9), preterm SGA 
(OR 10.0) and term SGA (OR 6.3) (51). Despite the division into groups, it is still difficult to 
make a completely fair comparison as all included infants in the study had a birth weight <2500 
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grams. Hinkle et al. found that women whose first pregnancy was complicated by a SGA birth 
had more than a four-fold increased risk for another SGA infant. An additional finding in the 
study of Hinkle et al. was that maternal short stature and pre-pregnancy underweight were 
significantly associated with a greater risk of both incident and recurrent SGA (52). These two 
studies present a similar conclusion; it is possible that the same factors responsible for 
LBW/SGA births in previous pregnancy may be operative in the current one. These factors may 
or may not be modifiable, indicating a need for a better understanding of the underlying 
pathophysiology of LBW/SGA delivery.  
To summarise, in our study maternal anthropometric factors and previous LBW child were the 
only variables significantly associated to SGA. This result is probably due to the etiology of 
SGA in the investigated areas and could be interpreted in mainly two ways, both which will be 
discussed further.  
The physiological explanation of SGA 
One possible theory to SGA outcome in this study population could be attributed to small but 
healthy parents, thus due to parental genetics and not IUGR. It is essential to keep in mind that 
the rate of IUGR is neither static or general but depends on the prevalence of risk factors and 
pathology within the population of interest. According to Deepak Sharma et al. 50-70 per cent 
of all SGA infants are constitutional small with foetal growth appropriate for maternal size and 
ethnicity (17). In a conversation with Dr Harindra Ranaweera, consultant obstetrician and 
gynaecologist at Thambuttegama Base hospital in Anuradhapura district, even a more extreme 
picture is emphasised. Based on his own clinical experience, he approximates more than 75 per 
cent of all SGA new-borns in the district to be small because of genetic predisposition. This 
statement is in accordance with the significant and high correlation of maternal weight, height 
and low BMI in this study. Moreover, factors responsible for LBW/SGA births in a previous 
pregnancy may operate during subsequent pregnancies as described earlier. By this means, it is 
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not odd that petite healthy mothers continue to give birth to small healthy children, which 
clarifies the almost four-fold increased risk of having a SGA infant with previous LBW birth. 
The absences of pathologic SFH-charts and clinical significant birth or postnatal complications 
in the study group also support the hypothesis that infants are constitutionally small rather than 
IUGR.  
The pathological explanation of SGA 
Despite the above-mentioned theory of constitutionally small babies, it is necessary to consider 
IUGR as a possible underlying driving force of SGA in the study group. Furthermore, several 
aspects tend to point in the direction of IUGR. First of all, the reliability of SFH measurements 
has been an issue of great debate since many studies have verified high false-negative rates for 
SGA (53). For example, the clinical condition polyhydramnios (high amount of amniotic fluid) 
can conceal a growth inhibition. It is also important to recall that the chart used in this study 
was based on a Western population and that the design made it unsatisfactory to interpret single 
measurements. In addition, many of the pregnancy records had no documented measurements 
at all. Missing SFH-data is a problem that has previously been noted. A nationwide evaluation 
carried out on the proper use of SFH-charts during antenatal follow-up in Sri Lanka have 
confirmed that the use of the charts is improper (54).  
Second, the significant association of maternal anthropometric factors and SGA seen in this 
study could be interpreted as operating through underlying factors correlated with maternal 
body size and thus be a function of confounding. Although available confounders were 
controlled for in the analysis, the found associations still may be partly driven by absent external 
factors. For instance, short stature may be correlated with malnutrition and low socioeconomic 
status, both highly associated with infant growth.  
Third, evaluation of gestational hypertension and pre-eclampsia was performed by the author 
of this rapport. Data was taken from registered measurements of blood pressure and urine 
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protein and interpreted according to the definitions. The definition of both variables requires 
two separate measurements of blood pressure >140/90. In some of the pregnancy records, one 
single measurement >140/90 was documented, however follow-up measurements were 
missing. In one of the records a single value of 140/90 was documented together with three plus 
on the dipstick right before delivery, and accordingly it looks like this delivery may have been 
a result of upcoming pre-eclampsia. Due to lack of further information in these regards, an 
underestimation of the incidence of gestational hypertension and pre-eclampsia may have 
occurred. In addition, handwritten information in the margins of the pregnancy records was 
common. These marks could be everything from important medical events to meaningless 
notes. Although the students had basic medical knowledge, in the end it is hard to appraise the 
validity of the information. Furthermore, inadequate documentation practice by the PHMs and 
medical officers is a presumable reason for low rate of neonatal complications documented in 
the pregnancy records. Given all previous aspects, presence of growth restricted infants in the 
investigated population must be considered. It seems that a combination of parental genetics 
and IUGR is the most likely source to SGA outcome in Anuradhapura district and that 
limitations of the study made it problematic to fully capture the whole picture. 
Borderline associations  
Consanguinity (p=0.074), anaemia in pregnancy (p=0.067) and absence of folic acid 
supplement in early pregnancy (p=0.062) gave borderline associations in the Chi square test, 
whereas in the multivariable analysis, none of these variables turned out to be significant. 
Previous research regarding these variables have reported contradictory results and they 
probably vary because of slightly dissimilar definitions, but also because of different reference 
populations for SGA.  
Marriage between relatives, consanguinity, has been associated with adverse child health 
outcomes since it increases homozygosity of recessive alleles. In some previous studies, the 
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outcome analysed has simply been LBW and they have demonstrated significant increased risk 
of LBW in consanguineous parents (55, 56). Out of the reviewed literature for this report, no 
study presenting a relation between consanguinity and SGA has been found. Nevertheless, a 
study from another developing country reported a significant decrease in birth weight for 
gestational age and no significant difference was observed between the first-and second-cousin 
marriages (57).  
As far as anaemia in pregnancy is concerned, prior studies have provided inconclusive 
evidences and it may be due to incomparable cut-off levels and analysis methods. This thesis 
showed no increased risk of SGA outcome in the final analysis. In a prospective study from 
another part of Sri Lanka, also conducted within two MOH areas, a similar result was 
publicized. In that study, no significant association between anaemia at first visit and delivery 
of a SGA baby was seen (58).   
Neither there was a beneficial effect of folic acid supplement in early pregnancy on decreasing 
the risk of SGA in the study group. A large prospective cohort study of 3647 women who were 
followed from the first trimester of pregnancy reported corresponding result (59).  
Although the three variables showed borderline associations, odds ratio and upper confidence 
intervals in the regression analysis were above one (>1), indicating that there could be a 
difference though it is not significant in this study. However, the variables may be clinical 
relevant and further investigations regarding these variables, preferably in a lager study group 
including socioeconomic and nutritional confounders, should be considered.  
Secondary aim findings 
Unfortunately, the question regarding weather SGA increases the risk of neonatal adverse 
outcomes could not be answered. A larger sample size would be necessary to be able to draw 
more reliable conclusions. However, caesarean section was more common among SGA infants 
than AGA infants. The indications of the CS were not recorded in the pregnancy records which 
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makes it difficult to clarify the underlying reason of the association. A possible explanation to 
the increased CS rate in the group of SGA could be intrauterine asphyxia, a condition which 
often demands a CS. WHO has set up a goal for 2025 to decrease non-medically indicated 
caesarean deliveries. This goal implies the need of further research in order to address the high 
rates of CS among SGA infants in Anuradhapura district.  
Study strength and weaknesses 
This is the first study to report risk factors for SGA infants in Anuradhapura district, Sri Lanka. 
The retrospective study design is a strength of this study as it gave opportunity to screen and 
sample a large amount of data from the pregnancy records. With interviews or surveys, 
socioeconomic factors would be easier to explore, but the required sample size is unreachable 
for a student thesis. Moreover, clinical factors would be lost. Including subjects from two 
demographically diverse MOH areas made the study sample more representative of the entire 
district. Another strength is that the studied population was matched for gestational age.  
Nevertheless, there are several possibly important limitations of this study. Firstly, the aim was 
originally to investigate an extensive range of potential risk factors. Due to discrepancy in 
received information, data about chronic hypertension and socioeconomic factors could not be 
studied as planned. This is believed to be the main weakness of the study. Chronic hypertension 
is considered one of the most common medical conditions in pregnancy and a review article 
performed by McCowan et al. demonstrates that studies from several countries have shown 
association with SGA (22). Consequently, it is essential to be aware of that these lost factors 
may be key determinants of SGA in Anuradhapura district, or confounders essential for 
accurate analysis. Secondly, all available records could not be screened as planned because of 
practical circumstances. For example, all PHMs battled the stress of heavy workload and to 
keep up they had to visit numerous mothers per day out in the field. Thus, all PHMs offices 
could not be visited and this diminished accordingly the study sample. Furthermore, in contrast 
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to some prior studies, young maternal age and antepartum haemorrhage presented no 
connection to the examined outcome. An explanation to this contradictory result could be low 
statistical power, which made it impossible to detect significant differences. A lager sample 
size may have allowed more conclusive results, as multivariable regression analysis in a larger 
population can reveal or reject correlations in a more confident manner. In addition, a fairly 
large part of the data was missing because of poor pregnancy record documentation by the 
PHMs and medical officers. As a consequence of a limited study sample and missing data, the 
results must be interpreted with caution.  
A third limitation relates to the studied outcome. Different study outcomes limit and make 
comparisons between studies more complex. In Sri Lanka, economic and medical resources are 
still relatively limited and to examine IUGR rather than SGA would be more problematic. The 
general difficulty of exploring IUGR is illustrated in the literature by the fact that studies on 
risk factors for LBW respectively SGA are more common than those for IUGR. By studying 
SGA instead of IUGR, the risk of healthy foetuses becoming subjects to extra monitoring and 
other types of interventions increases, which may waste resources in an already resource-poor 
country. However, this must be put in perspective to the profit of reducing neonatal morbidity 
and mortality. 
Implications  
This was a small case-control study with residual confounding and the results should therefore 
be viewed primary as hypothesis-generating. The findings of this study suggest further 
examination whether women in Anuradhapura district are small because of physiologic or 
pathologic effects. This distinction is essential since pathologic maternal growth restriction and 
malnutrition can be improved. Maternal stature is a composite indicator representing parental 
genetics and environmental effects on the growing period of childhood. Researcher Karri 
Silventoinen states that unlike modern Western societies, in poorer settings a larger percentage 
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of variation in height within the population is attributable to the environment over genetics 
(60).  According to data from UNICEF, Sri Lanka has been struggling with child undernutrition 
and stunting for many years now, and it is still a problem. Girls that are born LBW/SGA grow 
into women of short stature, who themselves are more likely to have LBW/SGA children. 
Unless the cycle is broken at some point, this situation will continue over generations resulting 
in an intergenerational cycle of undernutrition (61). To decrease future SGA infants in 
Anuradhapura district, a possible intervention might be improvement of the nutritional status 
of children and adolescents. UNICEF also present data of pre-pregnancy undernutrition in Sri 
Lanka. WHO´s global nutrition targets for 2025 recommend balanced protein–energy 
supplementation to selected women to reduce SGA and this could be a solution to the postulated 
issue of pre-pregnancy undernutrition. Although poor dietary intake and poor availability of 
nutrients already are established as direct causes of undernutrition in women in South-Asia, 
underlying social determinants have in the last decade been emphasised to be important aspects 
when it comes to maternal nutrition and pre-pregnancy weight (62). This signifies that the 
combination of nutrition specific interventions and interventions to assess and tackle 
wider social determinants could be valuable. Focus on empowerment of women and reduction 
of gender and income inequity may be an effective method to eventually lessen SGA outcome 
in Anuradhapura district. Nevertheless, regardless of the discussion above no causal 
relationship of undernutrition and SGA has been confirmed by this study. For the time being, 
prevention programs to provide special attention to mothers with previous history of LBW child 
are suggested. 
Customized versus population-based birth weight-for-gestational-age chart 
Gardosi et al. state that population-based weigh-for-gestational-age charts do not fully capture 
the burden of growth restriction and they promote customized charts, adjusted for pre-
pregnancy weight, height, infant sex, parity and ethnic origin (63). This research group state 
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that customized charts would improve the distinction between physiological and pathological 
variation in foetal size and provide a better estimate of infants with high morbidity and mortality 
(64). There are studies pointing at SGA infants by customized centiles are more likely to have 
abnormal umbilical artery doppler velocimetry findings, to be stillborn, to have low Apgar 
scores and to die in the neonatal period (65). Application of a customized chart might be 
successful in a high-income country, but it can be more difficult in a population with poorer 
living conditions, where small mothers not only are a result of physiological effects. It is 
important to emphasize the need of a systematic investigation of the reason of small women in 
Anuradhapura district before customized charts becomes praxis, this as a normalization of 
pathologically small women may have profound consequences. 
 
Conclusions 
 
SGA infants in Anuradhapura district have a significant relation to the maternal factors low 
pre-pregnancy weight and BMI, short stature and previous LBW births. Based on the result 
from this study, it is not possible to conclude if these observed risk factors depend on parental 
genetics or environmental factors, and hence are modifiable or not. Further studies investigating 
whether mothers in the district are small because of physiological or pathological effects would 
be an important next step. In the meantime, special attention directed towards mothers with 
previous LBW child is suggested. In future research, the result and methodological 
considerations from this study could be used to improve study design and methods. Taken 
together, the need of studies with larger sample size and inclusion of nutritional and 
socioeconomic confounders should be highlighted in order to come closer the truth regarding 
risk factors of SGA in Anuradhapura district.  
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Populärvetenskaplig sammanfattning 
Riskfaktorer för tillväxthämmade barn i distriktet Anuradhapura, Sri Lanka. 
Låg födelsevikt är ett stort globalt hälsoproblem som bidrar till en majoritet av alla dödsfall 
under nyföddhetsperioden. Att ett barn har låg vikt vid födseln beror i huvudsak på två saker; 
en för tidig födsel eller att barnet fötts för litet för tiden (för små för sin födelsevecka), där den 
sistnämnda ibland beror på ogynnsam tillväxthämning inne i livmodern. Denna grupp utgör 
även majoriteten av de barn som föds med för låg vikt i låg- och medelinkomstländer. 
I denna fall-kontroll studie, genomförd i distriktet Anuradhapura i centrala Sri Lanka, 
undersöktes 36 olika faktorer samlade från graviditetsjournaler från åren 2014–2017 och deras 
koppling till att föda ett för litet barn. Totalt samlades 136 fall och 272 kontroller in. Man fann 
att en initial vikt hos mamman <50 kg, Body Mass Index (BMI) <18.5 respektive ≥ 25 och 
längd ≤150 cm ökade risken för ett för litet barn. Dessutom nära fyrfaldigades risken om 
mamman tidigare fött ett barn med låg födelsevikt. Att övervikt visade sig innebära en 
riskökning tros beror på en indirekt effekt medierad av andra faktorer som inte gavs möjlighet 
att studera.  
Det är dock inte uppenbart att utifrån den här studien säga om resultatet beror på fysiologiska 
eller sjukliga mekanismer. En tänkbar förklaring till för små barn är kortväxta men friska 
mödrar. Denna orsak ger således inte ökad risk för barnet att drabbas av sjukdom eller död, utan 
grundar sig i normal ärftlighet och dessa mammor kommer även i fortsättningen att föda barn 
med låg födelsevikt. Emellertid finns det en risk att resultatet istället beror på att mammorna 
under sin egen barndom varit utsatta för undernäring och därmed inte kunnat växa sig så långa 
som deras gener avsett. Dessutom kan mammans låga vikt före graviditet bero på långvarig 
undernäring. Om denna förklaring till små barn stämmer finns det möjlighet till åtgärder som 
skulle kunna minska andelen framtida födslar av för små barn i distriktet Anuradhapura.  
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Den andra fråga man ställde i studien var om barn för små för sin födelsevecka hade en ökad 
risk för ogynnsamma utfall i form av komplikationer eller död, men även om det fanns en 
association till en särskild förlossningsmetod. Gällande frågan om ökad risk för ogynnsamma 
utfall gick materialet tyvärr inte att analysera statistiskt på grund av för få observationer. 
Däremot visade det sig att hela 41,9 procent av de för små barnen förlöstes med kejsarsnitt 
jämfört med endast 29,4 procent av de normalviktiga barnen. 
Slutsatsen man kan dra är att i distriktet Anuradhapura har en kort mamma med låg vikt före 
sin graviditet en förhöjd risk att föda ett för litet barn.  Det är dock svårt att utifrån denna studie 
säga något om orsaken till att mammans kroppskonstitution påverkar utfallet – kan det vara 
ärftlighet eller kanske undernäring? Det behövs följaktligen vidare studier för att kunna dra 
säkrare slutsatser. Fram till dess föreslås att mammor som tidigare fött barn med låg födelsevikt 
riktas särskild uppmärksamhet i preventionsprogram.  
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